Novo Nordisk's pricing strategies while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price gouging, stating the stark contrast among U.S. costs and people in Europe and copyright. California biotech behemoth Amgen ditched progr